Literature DB >> 20921222

Aggregation of detergent-insoluble tau is involved in neuronal loss but not in synaptic loss.

Tetsuya Kimura1, Tetsuya Fukuda, Naruhiko Sahara, Shunji Yamashita, Miyuki Murayama, Tatsuya Mizoroki, Yuji Yoshiike, Boyoung Lee, Ioannis Sotiropoulos, Sumihiro Maeda, Akihiko Takashima.   

Abstract

Neurofibrillary tangles (NFTs), which consist of highly phosphorylated tau, are hallmarks of neurodegenerative diseases including Alzheimer disease (AD). In neurodegenerative diseases, neuronal dysfunction due to neuronal loss and synaptic loss accompanies NFT formation, suggesting that a process associated with NFT formation may be involved in neuronal dysfunction. To clarify the relationship between the tau aggregation process and synapse and neuronal loss, we compared two lines of mice expressing human tau with or without an aggregation-prone P301L mutation. P301L tau transgenic (Tg) mice exhibited neuronal loss and produced sarcosyl-insoluble tau in old age but did not exhibit synaptic loss and memory impairment. By contrast, wild-type tau Tg mice neither exhibited neuronal loss nor produced sarcosyl-insoluble tau but did exhibit synaptic loss and memory impairment. Moreover, P301L tau was less phosphorylated than wild-type tau, suggesting that the tau phosphorylation state is involved in synaptic loss, whereas the tau aggregation state is involved in neuronal loss. Finally, increasing concentrations of insoluble tau aggregates leads to the formation of fibrillar tau, which causes NFTs to form.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20921222      PMCID: PMC2992302          DOI: 10.1074/jbc.M110.136630

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  Molecular genetics of chromosome 17 tauopathies.

Authors:  M Hutton
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

2.  Neuronal Cdc2-like protein kinase (Cdk5/p25) is associated with protein phosphatase 1 and phosphorylates inhibitor-2.

Authors:  A Agarwal-Mawal; H K Paudel
Journal:  J Biol Chem       Date:  2001-04-24       Impact factor: 5.157

3.  Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias.

Authors:  S Barghorn; Q Zheng-Fischhöfer; M Ackmann; J Biernat; M von Bergen; E M Mandelkow; E Mandelkow
Journal:  Biochemistry       Date:  2000-09-26       Impact factor: 3.162

4.  Molecular analysis of mutant and wild-type tau deposited in the brain affected by the FTDP-17 R406W mutation.

Authors:  T Miyasaka; M Morishima-Kawashima; R Ravid; P Heutink; J C van Swieten; K Nagashima; Y Ihara
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

5.  Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau.

Authors:  K Tanemura; T Akagi; M Murayama; N Kikuchi; O Murayama; T Hashikawa; Y Yoshiike; J M Park; K Matsuda; S Nakao; X Sun; S Sato; H Yamaguchi; A Takashima
Journal:  Neurobiol Dis       Date:  2001-12       Impact factor: 5.996

6.  Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.

Authors:  M Pérez; E Ribe; A Rubio; F Lim; M A Morán; P Gómez Ramos; I Ferrer; M T G Isla; J Avila
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

Review 7.  Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease.

Authors:  M Goedert; M G Spillantini
Journal:  Biochim Biophys Acta       Date:  2000-07-26

Review 8.  Tau and transgenic animal models.

Authors:  J Götz
Journal:  Brain Res Brain Res Rev       Date:  2001-07

9.  Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure.

Authors:  M von Bergen; S Barghorn; L Li; A Marx; J Biernat; E M Mandelkow; E Mandelkow
Journal:  J Biol Chem       Date:  2001-10-17       Impact factor: 5.157

10.  GSK-3beta is required for memory reconsolidation in adult brain.

Authors:  Tetsuya Kimura; Shunji Yamashita; Shinobu Nakao; Jung-Mi Park; Miyuki Murayama; Tatsuya Mizoroki; Yuji Yoshiike; Naruhiko Sahara; Akihiko Takashima
Journal:  PLoS One       Date:  2008-10-28       Impact factor: 3.240

View more
  43 in total

Review 1.  Mouse models of Alzheimer's disease.

Authors:  Alicia M Hall; Erik D Roberson
Journal:  Brain Res Bull       Date:  2011-11-28       Impact factor: 4.077

2.  Ectopic Expression Induces Abnormal Somatodendritic Distribution of Tau in the Mouse Brain.

Authors:  Atsuko Kubo; Shouyou Ueda; Ayaka Yamane; Satoko Wada-Kakuda; Mai Narita; Makoto Matsuyama; Akane Nomori; Akihiko Takashima; Taisuke Kato; Osamu Onodera; Motohito Goto; Mamoru Ito; Takami Tomiyama; Hiroshi Mori; Shigeo Murayama; Yasuo Ihara; Hiroaki Misonou; Tomohiro Miyasaka
Journal:  J Neurosci       Date:  2019-06-24       Impact factor: 6.167

3.  Spleen tyrosine kinase (SYK) blocks autophagic Tau degradation in vitro and in vivo.

Authors:  Jonas Elias Schweig; Hailan Yao; Kyle Coppola; Chao Jin; Fiona Crawford; Michael Mullan; Daniel Paris
Journal:  J Biol Chem       Date:  2019-07-19       Impact factor: 5.157

4.  Modification of Tau by 8-Nitroguanosine 3',5'-Cyclic Monophosphate (8-Nitro-cGMP): EFFECTS OF NITRIC OXIDE-LINKED CHEMICAL MODIFICATION ON TAU AGGREGATION.

Authors:  Jun Yoshitake; Yoshiyuki Soeda; Tomoaki Ida; Akio Sumioka; Misato Yoshikawa; Kenji Matsushita; Takaaki Akaike; Akihiko Takashima
Journal:  J Biol Chem       Date:  2016-09-06       Impact factor: 5.157

5.  Soluble forms of tau are toxic in Alzheimer's disease.

Authors:  Katherine J Kopeikina; Bradley T Hyman; Tara L Spires-Jones
Journal:  Transl Neurosci       Date:  2012-09       Impact factor: 1.757

6.  Dysregulation of autophagy and stress granule-related proteins in stress-driven Tau pathology.

Authors:  Joana Margarida Silva; Sara Rodrigues; Belém Sampaio-Marques; Patrícia Gomes; Andreia Neves-Carvalho; Chrysoula Dioli; Carina Soares-Cunha; Brandon F Mazuik; Akihiko Takashima; Paula Ludovico; Benjamin Wolozin; Nuno Sousa; Ioannis Sotiropoulos
Journal:  Cell Death Differ       Date:  2018-11-15       Impact factor: 15.828

7.  Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model.

Authors:  Astrid Sydow; Ann Van der Jeugd; Fang Zheng; Tariq Ahmed; Detlef Balschun; Olga Petrova; Dagmar Drexler; Lepu Zhou; Gabriele Rune; Eckhard Mandelkow; Rudi D'Hooge; Christian Alzheimer; Eva-Maria Mandelkow
Journal:  J Mol Neurosci       Date:  2011-08-06       Impact factor: 3.444

8.  HDAC6 mutations rescue human tau-induced microtubule defects in Drosophila.

Authors:  Ying Xiong; Kai Zhao; Jiaxi Wu; Zhiheng Xu; Shan Jin; Yong Q Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

9.  The Neurotoxic TAU45-230 Fragment Accumulates in Upper and Lower Motor Neurons in Amyotrophic Lateral Sclerosis Subjects.

Authors:  Claudia R Vintilescu; Sana Afreen; Ashlee E Rubino; Adriana Ferreira
Journal:  Mol Med       Date:  2016-08-03       Impact factor: 6.354

10.  Synaptic alterations in the rTg4510 mouse model of tauopathy.

Authors:  Katherine J Kopeikina; Manuela Polydoro; Hwan-Ching Tai; Erich Yaeger; George A Carlson; Rose Pitstick; Bradley T Hyman; Tara L Spires-Jones
Journal:  J Comp Neurol       Date:  2013-04-15       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.